rs35219531
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001377540.1(SLMAP):c.1968T>A(p.Leu656Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0254 in 1,613,962 control chromosomes in the GnomAD database, including 677 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.016 ( 31 hom., cov: 32)
Exomes 𝑓: 0.026 ( 646 hom. )
Consequence
SLMAP
NM_001377540.1 synonymous
NM_001377540.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.277
Publications
4 publications found
Genes affected
SLMAP (HGNC:16643): (sarcolemma associated protein) This gene encodes a component of a conserved striatin-interacting phosphatase and kinase complex. Striatin family complexes participate in a variety of cellular processes including signaling, cell cycle control, cell migration, Golgi assembly, and apoptosis. The protein encoded by this gene is a coiled-coil, tail-anchored membrane protein with a single C-terminal transmembrane domain that is posttranslationally inserted into membranes. Mutations in this gene are associated with Brugada syndrome, a cardiac channelopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2015]
SLMAP Gene-Disease associations (from GenCC):
- Brugada syndromeInheritance: Unknown, AD Classification: SUPPORTIVE, LIMITED, NO_KNOWN Submitted by: Genomics England PanelApp, Orphanet, ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant 3-57912649-T-A is Benign according to our data. Variant chr3-57912649-T-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 240722.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.277 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0161 (2449/152298) while in subpopulation NFE AF = 0.0286 (1948/68018). AF 95% confidence interval is 0.0276. There are 31 homozygotes in GnomAd4. There are 1092 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 2449 Unknown,AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SLMAP | NM_001377540.1 | c.1968T>A | p.Leu656Leu | synonymous_variant | Exon 20 of 25 | ENST00000671191.1 | NP_001364469.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SLMAP | ENST00000671191.1 | c.1968T>A | p.Leu656Leu | synonymous_variant | Exon 20 of 25 | NM_001377540.1 | ENSP00000499458.1 |
Frequencies
GnomAD3 genomes AF: 0.0161 AC: 2449AN: 152180Hom.: 31 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
2449
AN:
152180
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0164 AC: 4115AN: 250368 AF XY: 0.0168 show subpopulations
GnomAD2 exomes
AF:
AC:
4115
AN:
250368
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0264 AC: 38609AN: 1461664Hom.: 646 Cov.: 31 AF XY: 0.0256 AC XY: 18634AN XY: 727162 show subpopulations
GnomAD4 exome
AF:
AC:
38609
AN:
1461664
Hom.:
Cov.:
31
AF XY:
AC XY:
18634
AN XY:
727162
show subpopulations
African (AFR)
AF:
AC:
120
AN:
33480
American (AMR)
AF:
AC:
291
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
102
AN:
26136
East Asian (EAS)
AF:
AC:
1
AN:
39694
South Asian (SAS)
AF:
AC:
485
AN:
86254
European-Finnish (FIN)
AF:
AC:
548
AN:
53312
Middle Eastern (MID)
AF:
AC:
11
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
35747
AN:
1111906
Other (OTH)
AF:
AC:
1304
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
1896
3792
5687
7583
9479
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1322
2644
3966
5288
6610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0161 AC: 2449AN: 152298Hom.: 31 Cov.: 32 AF XY: 0.0147 AC XY: 1092AN XY: 74466 show subpopulations
GnomAD4 genome
AF:
AC:
2449
AN:
152298
Hom.:
Cov.:
32
AF XY:
AC XY:
1092
AN XY:
74466
show subpopulations
African (AFR)
AF:
AC:
207
AN:
41556
American (AMR)
AF:
AC:
139
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
7
AN:
3468
East Asian (EAS)
AF:
AC:
1
AN:
5194
South Asian (SAS)
AF:
AC:
19
AN:
4826
European-Finnish (FIN)
AF:
AC:
98
AN:
10616
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1948
AN:
68018
Other (OTH)
AF:
AC:
29
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
121
242
362
483
604
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Sep 08, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
May 28, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Brugada syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.